Diagnostic options · UAE

Single Gene tests in Dubai & UAE

Compare available Single Gene tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

332

Listed price range

2,000.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene test prices

Showing 286–300 of 332 matching tests.

Single Gene diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4998 SOX18 Gene Hypotrichosis‑Lymphedema‑Telangiectasia Syndrome Genetic Test This genetic test evaluates the SOX18 gene for pathogenic variants associated with Hypotrichosis‑Lymphedema‑Telangiectasia Syndrome (HLTS).	Peripheral whole blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SOX18 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory"] Indications ["Clinical features suggestive of HLTS", "Family history of HLTS"] Measurement technique Confirm with laboratory Codes LOINC: 88550-6 ICD-10: Q87.8 Clinical summary This genetic test evaluates the SOX18 gene for pathogenic variants associated with Hypotrichosis‑Lymphedema‑Telangiectasia Syndrome (HLTS).
TEST-4498 SPTLC1 Gene HSAN1 Genetic Test This genetic test detects pathogenic variants in the SPTLC1 gene to confirm a diagnosis of hereditary sensory and autonomic neuropathy type 1 (HSAN1).	Peripheral whole blood, extracted DNA, or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPTLC1 gene", "Genetic predisposition to HSAN1"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected hereditary sensory and autonomic neuropathy type 1 (HSAN1)", "Family history of HSAN1", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 94216-8 ICD-10: G60.8 Clinical summary This genetic test detects pathogenic variants in the SPTLC1 gene to confirm a diagnosis of hereditary sensory and autonomic neuropathy type 1 (HSAN1).
TEST-5566 SRPX2 Gene DNA Test for Rolandic Epilepsy, Intellectual Disability & Speech Dyspraxia This test identifies pathogenic variants in the SRPX2 gene associated with Rolandic epilepsy, intellectual disability, and speech dyspraxia.	Peripheral Whole Blood, Dried Blood Spot (DBS), or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SRPX2 gene", "Coding region and splice site variants"] Parameters [] Preparation ["No special preparation is needed.", "Pre-test genetic counselling session is strongly recommended.", "Do not discontinue antiepileptic medications without consulting your treating neurologist."] Indications ["Diagnosis of SRPX2-related disorders", "Familial risk assessment", "Personalized management guidance"] Measurement technique Confirm with laboratory Codes LOINC: 51955-5 ICD-10: Z13.71, G40.0, F70, R48.2 Clinical summary This test identifies pathogenic variants in the SRPX2 gene associated with Rolandic epilepsy, intellectual disability, and speech dyspraxia.
TEST-4955 ST3GAL3 Gene (Mental Retardation, Autosomal Recessive Type 12) Genetic Test This genetic test identifies pathogenic variants in the ST3GAL3 gene associated with autosomal recessive intellectual disability type 12.	Peripheral whole blood or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ST3GAL3 gene", "Single-nucleotide variants", "Missense variants", "Nonsense variants", "Splice-site variants", "Small insertions/deletions (indels)"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Suspected autosomal recessive intellectual disability type 12", "Family history of intellectual disability"] Measurement technique Confirm with laboratory Codes LOINC: 82914-3 ICD-10: Q87.8 Clinical summary This genetic test identifies pathogenic variants in the ST3GAL3 gene associated with autosomal recessive intellectual disability type 12.
TEST-5363 STIM1 Gene Myopathy, Tubular Aggregate, Type 1 Genetic Test This test identifies pathogenic variants in the STIM1 gene associated with tubular aggregate myopathy type 1.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card	21 – 28 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["STIM1 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory", "Avoid heparin-based anticoagulants"] Indications ["Suspected STIM1-related tubular aggregate myopathy", "Congenital neuromuscular disorder investigation", "Genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 94233-3 ICD-10: G71.03 Clinical summary This test identifies pathogenic variants in the STIM1 gene associated with tubular aggregate myopathy type 1.
TEST-2420 STRADA Gene Polyhydramnios, Megalencephaly, and Symptomatic Epilepsy Genetic Test This test evaluates the STRADA gene for pathogenic variants associated with Polyhydramnios, Megalencephaly, and Symptomatic Epilepsy (PMSE) syndrome.	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the STRADA gene"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Suspected PMSE syndrome", "Family history of PMSE syndrome", "Carrier screening for at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: Q87.8 Clinical summary This test evaluates the STRADA gene for pathogenic variants associated with Polyhydramnios, Megalencephaly, and Symptomatic Epilepsy (PMSE) syndrome.
TEST-4518 STX1B Gene Generalized Epilepsy with Febrile Seizures Plus Type 9 Genetic Test This test analyzes the STX1B gene for mutations associated with generalized epilepsy with febrile seizures plus (GEFS+) type 9.	Whole blood (EDTA) or FTA card finger-prick	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["STX1B gene sequence", "Pathogenic variants (SNVs, indels)"] Parameters [] Preparation ["No fasting required", "Continue all prescribed medications"] Indications ["Suspected GEFS+ type 9", "Family history of GEFS+", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 85443-8 ICD-10: G40.3, R56.0 Clinical summary This test analyzes the STX1B gene for mutations associated with generalized epilepsy with febrile seizures plus (GEFS+) type 9.
TEST-4651 SURF1 Gene Analysis (Leigh Syndrome, COX Deficiency) Test This test identifies pathogenic variants within the SURF1 gene associated with Leigh syndrome and cytochrome c oxidase (COX) deficiency.	Peripheral whole blood (3–5 mL in EDTA tube); alternative buccal swab accepted for paediatric cases	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SURF1 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["No special dietary preparation required", "Bring valid Emirates ID or passport", "Bring prior neurological imaging reports", "Bring previous genetic testing records", "Bring a complete list of current medications"] Indications ["Suspected Leigh syndrome", "Suspected mitochondrial disorder", "Cytochrome c oxidase (COX) deficiency"] Measurement technique Confirm with laboratory Codes LOINC: 101388-0 ICD-10: G31.82 Clinical summary This test identifies pathogenic variants within the SURF1 gene associated with Leigh syndrome and cytochrome c oxidase (COX) deficiency.
TEST-4379 SYN1 Gene Epilepsy Test (X-Linked, Genetic) This test analyzes the SYN1 gene to identify mutations associated with X-linked epilepsy and related neurodevelopmental disorders.	Peripheral whole blood (EDTA), extracted DNA, or dried blood spot	3 to 4 Weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SYN1 gene coding region variants", "SYN1 gene splice-site variants", "SYN1 gene copy-number variants"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Diagnosis of X-linked epilepsy", "Genetic counselling for families with X-linked neurodevelopmental disorders", "Cascade screening of at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G40.89, F70 Clinical summary This test analyzes the SYN1 gene to identify mutations associated with X-linked epilepsy and related neurodevelopmental disorders.
TEST-5063 SYP Gene X-Linked Intellectual Disability Type 96 Genetic Test This test analyzes the SYP gene for pathogenic variants associated with X-linked intellectual disability type 96.	Whole Blood (3–5 mL in EDTA), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SYP gene coding region", "SYP gene flanking splice sites"] Parameters [] Preparation [] Indications ["Suspected X-linked intellectual disability type 96", "Family history of X-linked intellectual disability"] Measurement technique Confirm with laboratory Codes LOINC: 81305-3 ICD-10: F78 Clinical summary This test analyzes the SYP gene for pathogenic variants associated with X-linked intellectual disability type 96.
TEST-5783 TALDO1 Gene Transaldolase Deficiency Genetic Test This genetic test identifies mutations in the TALDO1 gene associated with transaldolase deficiency.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TALDO1 gene", "Single Nucleotide Variants (SNVs)", "Indels", "Exon-level Copy Number Variants (CNVs)"] Parameters [] Preparation ["No fasting required", "Genetic counselling session required before sample submission"] Indications ["Suspected transaldolase deficiency", "Family history of transaldolase deficiency", "Evaluation of inborn errors of metabolism"] Measurement technique Confirm with laboratory Codes LOINC: 81271-5 ICD-10: E74.89 Clinical summary This genetic test identifies mutations in the TALDO1 gene associated with transaldolase deficiency.
TEST-2739 TBX5 Gene Holt-Oram Syndrome Genetic Test This genetic test analyzes the TBX5 gene to detect variants associated with Holt-Oram syndrome.	Whole blood (EDTA tube), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)", "Deep intronic variants"] Parameters [] Preparation [] Indications ["Suspected Holt-Oram syndrome based on clinical presentation", "Family history of Holt-Oram syndrome", "Genetic counselling for individuals with relevant clinical features"] Measurement technique Confirm with laboratory Codes LOINC: 100267-2 ICD-10: Q87.2 Clinical summary This genetic test analyzes the TBX5 gene to detect variants associated with Holt-Oram syndrome.
TEST-3588 TGFBI Gene Corneal Dystrophy Genetic Testing (NGS) Test This test identifies pathogenic variants in the TGFBI gene associated with epithelial basement membrane corneal dystrophy.	Peripheral whole blood (venous) or FTA card (dried blood spot) or previously extracted DNA	3 to 4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TGFBI gene"] Parameters [] Preparation ["No fasting or dietary restrictions required", "Inform the team of any anticoagulant use", "Mandatory pre-test genetic counselling session required"] Indications ["Diagnosis of epithelial basement membrane corneal dystrophy", "Genetic counselling for families with corneal dystrophy", "Guiding management planning for hereditary corneal conditions"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: H18.53 Clinical summary This test identifies pathogenic variants in the TGFBI gene associated with epithelial basement membrane corneal dystrophy.
TEST-5091 TK2 Gene Mitochondrial DNA Depletion Syndrome Genetic Test (NGS) This test detects pathogenic variants in the TK2 gene associated with mitochondrial DNA depletion syndrome.	Whole blood, extracted DNA, dried blood spot (FTA card)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in TK2 gene", "Single nucleotide variants (SNVs)", "Insertions and deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation ["No fasting required.", "Provide detailed clinical history.", "Attend a pre-test genetic counselling session.", "Document a three-generation pedigree."] Indications ["Suspected mitochondrial DNA depletion syndrome", "Family planning for inherited disorders", "Diagnosis of progressive neurological disorders in infancy or childhood"] Measurement technique Confirm with laboratory Codes LOINC: 87809-3 ICD-10: E88.8 Clinical summary This test detects pathogenic variants in the TK2 gene associated with mitochondrial DNA depletion syndrome.
TEST-4506 TMEM173 Gene (STING) Vasculopathy Genetic Test This test identifies pathogenic variants in the TMEM173 gene, confirming a diagnosis of STING-associated vasculopathy with onset in infancy (SAVI).	Whole Blood (EDTA) or Extracted DNA	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TMEM173 gene", "Single-nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation ["Mandatory pre-test genetic counseling session.", "No specific fasting required.", "No medication adjustments required unless directed by physician."] Indications ["Suspected STING-associated vasculopathy with onset in infancy (SAVI)", "Unexplained early-onset systemic inflammation", "Skin vasculitis", "Interstitial lung disease"] Measurement technique Confirm with laboratory Codes LOINC: 91856-0 ICD-10: M35.8 Clinical summary This test identifies pathogenic variants in the TMEM173 gene, confirming a diagnosis of STING-associated vasculopathy with onset in infancy (SAVI).

Category overview

Single Gene: overview

When clinical symptoms or family history point directly toward a specific inherited condition, highly focused genetic testing provides the exact, rapid insights necessary for peace of mind. Integrated into our advanced Molecular Genetics services, Single Gene testing meticulously analyzes one specific gene for known disease-causing mutations. Utilizing cutting-edge diagnostic technology, this highly focused molecular screening helps confirm or rule out precise genetic traits, safely guiding targeted medical interventions and family planning strategies. Recognized for specialized diagnostic excellence among diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and incredibly efficient turnaround times. Take an informed step forward in your health journey—schedule your single gene testing in UAE, book a secure home sample collection, or reach out to our expert medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.